DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Sandborn WJ, Rutgeerts P, Gasnik C. et al.
Long-term efficacy and safety of Ustekinumab for Crohnʼs disease: Results from IM-UNITI long-term extension through 2 years.
J Crohns Colitis 2017;
11 (Suppl. 01) S6(OP010)
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.